nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Vincristine—muscle cancer	0.386	0.53	CbGbCtD
Bosentan—ABCB11—Doxorubicin—muscle cancer	0.242	0.331	CbGbCtD
Bosentan—CYP3A4—Vincristine—muscle cancer	0.0397	0.0545	CbGbCtD
Bosentan—CYP3A4—Etoposide—muscle cancer	0.0364	0.0499	CbGbCtD
Bosentan—CYP3A4—Doxorubicin—muscle cancer	0.0248	0.034	CbGbCtD
Bosentan—Vertigo—Etoposide—muscle cancer	0.000555	0.00205	CcSEcCtD
Bosentan—Leukopenia—Etoposide—muscle cancer	0.000553	0.00204	CcSEcCtD
Bosentan—Abdominal pain—Dactinomycin—muscle cancer	0.000551	0.00203	CcSEcCtD
Bosentan—Body temperature increased—Dactinomycin—muscle cancer	0.000551	0.00203	CcSEcCtD
Bosentan—Hypoglycaemia—Doxorubicin—muscle cancer	0.000545	0.00201	CcSEcCtD
Bosentan—Cardiac failure—Doxorubicin—muscle cancer	0.000545	0.00201	CcSEcCtD
Bosentan—Loss of consciousness—Etoposide—muscle cancer	0.000543	0.002	CcSEcCtD
Bosentan—Lethargy—Doxorubicin—muscle cancer	0.000543	0.002	CcSEcCtD
Bosentan—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000543	0.002	CcSEcCtD
Bosentan—Decreased appetite—Vincristine—muscle cancer	0.000541	0.002	CcSEcCtD
Bosentan—Cough—Etoposide—muscle cancer	0.000539	0.00199	CcSEcCtD
Bosentan—Gastrointestinal disorder—Vincristine—muscle cancer	0.000537	0.00198	CcSEcCtD
Bosentan—Fatigue—Vincristine—muscle cancer	0.000536	0.00198	CcSEcCtD
Bosentan—Hyponatraemia—Doxorubicin—muscle cancer	0.000534	0.00197	CcSEcCtD
Bosentan—Pain—Vincristine—muscle cancer	0.000532	0.00196	CcSEcCtD
Bosentan—Constipation—Vincristine—muscle cancer	0.000532	0.00196	CcSEcCtD
Bosentan—Pain in extremity—Doxorubicin—muscle cancer	0.000532	0.00196	CcSEcCtD
Bosentan—Asthma—Methotrexate—muscle cancer	0.000531	0.00196	CcSEcCtD
Bosentan—Chest pain—Etoposide—muscle cancer	0.000526	0.00194	CcSEcCtD
Bosentan—Eosinophilia—Methotrexate—muscle cancer	0.000526	0.00194	CcSEcCtD
Bosentan—Affect lability—Doxorubicin—muscle cancer	0.000524	0.00193	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000522	0.00193	CcSEcCtD
Bosentan—Discomfort—Etoposide—muscle cancer	0.000519	0.00192	CcSEcCtD
Bosentan—Hypersensitivity—Dactinomycin—muscle cancer	0.000513	0.00189	CcSEcCtD
Bosentan—Gastrointestinal pain—Vincristine—muscle cancer	0.000509	0.00188	CcSEcCtD
Bosentan—Cardiac arrest—Doxorubicin—muscle cancer	0.000506	0.00187	CcSEcCtD
Bosentan—Anaphylactic shock—Etoposide—muscle cancer	0.000504	0.00186	CcSEcCtD
Bosentan—Mood swings—Doxorubicin—muscle cancer	0.000504	0.00186	CcSEcCtD
Bosentan—Infection—Etoposide—muscle cancer	0.000501	0.00185	CcSEcCtD
Bosentan—Asthenia—Dactinomycin—muscle cancer	0.0005	0.00184	CcSEcCtD
Bosentan—Dysuria—Methotrexate—muscle cancer	0.000496	0.00183	CcSEcCtD
Bosentan—Neutropenia—Methotrexate—muscle cancer	0.000496	0.00183	CcSEcCtD
Bosentan—Dehydration—Doxorubicin—muscle cancer	0.000495	0.00182	CcSEcCtD
Bosentan—Thrombocytopenia—Etoposide—muscle cancer	0.000493	0.00182	CcSEcCtD
Bosentan—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000493	0.00182	CcSEcCtD
Bosentan—Tachycardia—Etoposide—muscle cancer	0.000492	0.00181	CcSEcCtD
Bosentan—Abdominal pain—Vincristine—muscle cancer	0.000492	0.00181	CcSEcCtD
Bosentan—Body temperature increased—Vincristine—muscle cancer	0.000492	0.00181	CcSEcCtD
Bosentan—Liver function test abnormal—Doxorubicin—muscle cancer	0.000491	0.00181	CcSEcCtD
Bosentan—Skin disorder—Etoposide—muscle cancer	0.00049	0.00181	CcSEcCtD
Bosentan—Dry skin—Doxorubicin—muscle cancer	0.000488	0.0018	CcSEcCtD
Bosentan—Hyperhidrosis—Etoposide—muscle cancer	0.000487	0.0018	CcSEcCtD
Bosentan—Abdominal pain upper—Doxorubicin—muscle cancer	0.000486	0.00179	CcSEcCtD
Bosentan—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000486	0.00179	CcSEcCtD
Bosentan—Hypokalaemia—Doxorubicin—muscle cancer	0.000484	0.00179	CcSEcCtD
Bosentan—Anorexia—Etoposide—muscle cancer	0.00048	0.00177	CcSEcCtD
Bosentan—Diarrhoea—Dactinomycin—muscle cancer	0.000476	0.00176	CcSEcCtD
Bosentan—Pneumonia—Methotrexate—muscle cancer	0.000476	0.00176	CcSEcCtD
Bosentan—Nasopharyngitis—Doxorubicin—muscle cancer	0.000476	0.00175	CcSEcCtD
Bosentan—Infestation NOS—Methotrexate—muscle cancer	0.000473	0.00175	CcSEcCtD
Bosentan—Infestation—Methotrexate—muscle cancer	0.000473	0.00175	CcSEcCtD
Bosentan—Hypotension—Etoposide—muscle cancer	0.000471	0.00174	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000469	0.00173	CcSEcCtD
Bosentan—Renal failure—Methotrexate—muscle cancer	0.000465	0.00172	CcSEcCtD
Bosentan—Abdominal distension—Doxorubicin—muscle cancer	0.000463	0.00171	CcSEcCtD
Bosentan—Stomatitis—Methotrexate—muscle cancer	0.000461	0.0017	CcSEcCtD
Bosentan—Conjunctivitis—Methotrexate—muscle cancer	0.00046	0.0017	CcSEcCtD
Bosentan—Influenza—Doxorubicin—muscle cancer	0.00046	0.0017	CcSEcCtD
Bosentan—Asthma—Doxorubicin—muscle cancer	0.00046	0.0017	CcSEcCtD
Bosentan—Hypersensitivity—Vincristine—muscle cancer	0.000458	0.00169	CcSEcCtD
Bosentan—Eosinophilia—Doxorubicin—muscle cancer	0.000455	0.00168	CcSEcCtD
Bosentan—Paraesthesia—Etoposide—muscle cancer	0.000453	0.00167	CcSEcCtD
Bosentan—Haematuria—Methotrexate—muscle cancer	0.000451	0.00167	CcSEcCtD
Bosentan—Dyspnoea—Etoposide—muscle cancer	0.000449	0.00166	CcSEcCtD
Bosentan—Somnolence—Etoposide—muscle cancer	0.000448	0.00165	CcSEcCtD
Bosentan—Angina pectoris—Doxorubicin—muscle cancer	0.000448	0.00165	CcSEcCtD
Bosentan—Hepatobiliary disease—Methotrexate—muscle cancer	0.000448	0.00165	CcSEcCtD
Bosentan—Epistaxis—Methotrexate—muscle cancer	0.000446	0.00165	CcSEcCtD
Bosentan—Asthenia—Vincristine—muscle cancer	0.000446	0.00165	CcSEcCtD
Bosentan—Vomiting—Dactinomycin—muscle cancer	0.000443	0.00163	CcSEcCtD
Bosentan—Bronchitis—Doxorubicin—muscle cancer	0.000442	0.00163	CcSEcCtD
Bosentan—Rash—Dactinomycin—muscle cancer	0.000439	0.00162	CcSEcCtD
Bosentan—Decreased appetite—Etoposide—muscle cancer	0.000438	0.00162	CcSEcCtD
Bosentan—Gastrointestinal disorder—Etoposide—muscle cancer	0.000435	0.00161	CcSEcCtD
Bosentan—Fatigue—Etoposide—muscle cancer	0.000435	0.0016	CcSEcCtD
Bosentan—Pain—Etoposide—muscle cancer	0.000431	0.00159	CcSEcCtD
Bosentan—Constipation—Etoposide—muscle cancer	0.000431	0.00159	CcSEcCtD
Bosentan—Dysuria—Doxorubicin—muscle cancer	0.00043	0.00159	CcSEcCtD
Bosentan—Neutropenia—Doxorubicin—muscle cancer	0.00043	0.00159	CcSEcCtD
Bosentan—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000427	0.00158	CcSEcCtD
Bosentan—Haemoglobin—Methotrexate—muscle cancer	0.000427	0.00158	CcSEcCtD
Bosentan—Diarrhoea—Vincristine—muscle cancer	0.000426	0.00157	CcSEcCtD
Bosentan—Haemorrhage—Methotrexate—muscle cancer	0.000425	0.00157	CcSEcCtD
Bosentan—Hepatitis—Methotrexate—muscle cancer	0.000425	0.00157	CcSEcCtD
Bosentan—Pollakiuria—Doxorubicin—muscle cancer	0.000425	0.00157	CcSEcCtD
Bosentan—Urinary tract disorder—Methotrexate—muscle cancer	0.00042	0.00155	CcSEcCtD
Bosentan—Weight increased—Doxorubicin—muscle cancer	0.000418	0.00154	CcSEcCtD
Bosentan—Urethral disorder—Methotrexate—muscle cancer	0.000417	0.00154	CcSEcCtD
Bosentan—Weight decreased—Doxorubicin—muscle cancer	0.000416	0.00153	CcSEcCtD
Bosentan—Hyperglycaemia—Doxorubicin—muscle cancer	0.000415	0.00153	CcSEcCtD
Bosentan—Nausea—Dactinomycin—muscle cancer	0.000414	0.00153	CcSEcCtD
Bosentan—Pneumonia—Doxorubicin—muscle cancer	0.000412	0.00152	CcSEcCtD
Bosentan—Gastrointestinal pain—Etoposide—muscle cancer	0.000412	0.00152	CcSEcCtD
Bosentan—Dizziness—Vincristine—muscle cancer	0.000411	0.00152	CcSEcCtD
Bosentan—Infestation NOS—Doxorubicin—muscle cancer	0.00041	0.00151	CcSEcCtD
Bosentan—Infestation—Doxorubicin—muscle cancer	0.00041	0.00151	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000406	0.0015	CcSEcCtD
Bosentan—Renal failure—Doxorubicin—muscle cancer	0.000403	0.00149	CcSEcCtD
Bosentan—Erythema multiforme—Methotrexate—muscle cancer	0.000402	0.00148	CcSEcCtD
Bosentan—Urticaria—Etoposide—muscle cancer	0.0004	0.00148	CcSEcCtD
Bosentan—Stomatitis—Doxorubicin—muscle cancer	0.0004	0.00147	CcSEcCtD
Bosentan—Jaundice—Doxorubicin—muscle cancer	0.0004	0.00147	CcSEcCtD
Bosentan—Abdominal pain—Etoposide—muscle cancer	0.000398	0.00147	CcSEcCtD
Bosentan—Body temperature increased—Etoposide—muscle cancer	0.000398	0.00147	CcSEcCtD
Bosentan—Conjunctivitis—Doxorubicin—muscle cancer	0.000398	0.00147	CcSEcCtD
Bosentan—Urinary tract infection—Doxorubicin—muscle cancer	0.000398	0.00147	CcSEcCtD
Bosentan—Eye disorder—Methotrexate—muscle cancer	0.000397	0.00147	CcSEcCtD
Bosentan—Tinnitus—Methotrexate—muscle cancer	0.000396	0.00146	CcSEcCtD
Bosentan—Vomiting—Vincristine—muscle cancer	0.000396	0.00146	CcSEcCtD
Bosentan—Cardiac disorder—Methotrexate—muscle cancer	0.000394	0.00145	CcSEcCtD
Bosentan—Rash—Vincristine—muscle cancer	0.000392	0.00145	CcSEcCtD
Bosentan—Dermatitis—Vincristine—muscle cancer	0.000392	0.00145	CcSEcCtD
Bosentan—Haematuria—Doxorubicin—muscle cancer	0.000391	0.00144	CcSEcCtD
Bosentan—Headache—Vincristine—muscle cancer	0.00039	0.00144	CcSEcCtD
Bosentan—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000388	0.00143	CcSEcCtD
Bosentan—Epistaxis—Doxorubicin—muscle cancer	0.000387	0.00143	CcSEcCtD
Bosentan—Angiopathy—Methotrexate—muscle cancer	0.000386	0.00142	CcSEcCtD
Bosentan—Sinusitis—Doxorubicin—muscle cancer	0.000385	0.00142	CcSEcCtD
Bosentan—Immune system disorder—Methotrexate—muscle cancer	0.000384	0.00142	CcSEcCtD
Bosentan—Mediastinal disorder—Methotrexate—muscle cancer	0.000383	0.00141	CcSEcCtD
Bosentan—Chills—Methotrexate—muscle cancer	0.000381	0.00141	CcSEcCtD
Bosentan—Bradycardia—Doxorubicin—muscle cancer	0.000375	0.00138	CcSEcCtD
Bosentan—Mental disorder—Methotrexate—muscle cancer	0.000372	0.00137	CcSEcCtD
Bosentan—Hypersensitivity—Etoposide—muscle cancer	0.000371	0.00137	CcSEcCtD
Bosentan—Malnutrition—Methotrexate—muscle cancer	0.00037	0.00136	CcSEcCtD
Bosentan—Erythema—Methotrexate—muscle cancer	0.00037	0.00136	CcSEcCtD
Bosentan—Haemoglobin—Doxorubicin—muscle cancer	0.00037	0.00136	CcSEcCtD
Bosentan—Nausea—Vincristine—muscle cancer	0.00037	0.00136	CcSEcCtD
Bosentan—Haemorrhage—Doxorubicin—muscle cancer	0.000368	0.00136	CcSEcCtD
Bosentan—Hepatitis—Doxorubicin—muscle cancer	0.000368	0.00136	CcSEcCtD
Bosentan—Hypoaesthesia—Doxorubicin—muscle cancer	0.000366	0.00135	CcSEcCtD
Bosentan—Urinary tract disorder—Doxorubicin—muscle cancer	0.000363	0.00134	CcSEcCtD
Bosentan—Oedema peripheral—Doxorubicin—muscle cancer	0.000362	0.00134	CcSEcCtD
Bosentan—Asthenia—Etoposide—muscle cancer	0.000362	0.00133	CcSEcCtD
Bosentan—Urethral disorder—Doxorubicin—muscle cancer	0.000361	0.00133	CcSEcCtD
Bosentan—Back pain—Methotrexate—muscle cancer	0.000358	0.00132	CcSEcCtD
Bosentan—Pruritus—Etoposide—muscle cancer	0.000357	0.00132	CcSEcCtD
Bosentan—Vision blurred—Methotrexate—muscle cancer	0.000349	0.00129	CcSEcCtD
Bosentan—Erythema multiforme—Doxorubicin—muscle cancer	0.000348	0.00128	CcSEcCtD
Bosentan—Diarrhoea—Etoposide—muscle cancer	0.000345	0.00127	CcSEcCtD
Bosentan—Eye disorder—Doxorubicin—muscle cancer	0.000344	0.00127	CcSEcCtD
Bosentan—Tinnitus—Doxorubicin—muscle cancer	0.000343	0.00127	CcSEcCtD
Bosentan—Anaemia—Methotrexate—muscle cancer	0.000342	0.00126	CcSEcCtD
Bosentan—Cardiac disorder—Doxorubicin—muscle cancer	0.000341	0.00126	CcSEcCtD
Bosentan—Flushing—Doxorubicin—muscle cancer	0.000341	0.00126	CcSEcCtD
Bosentan—Angiopathy—Doxorubicin—muscle cancer	0.000334	0.00123	CcSEcCtD
Bosentan—Dizziness—Etoposide—muscle cancer	0.000333	0.00123	CcSEcCtD
Bosentan—Immune system disorder—Doxorubicin—muscle cancer	0.000332	0.00123	CcSEcCtD
Bosentan—Vertigo—Methotrexate—muscle cancer	0.000332	0.00123	CcSEcCtD
Bosentan—Mediastinal disorder—Doxorubicin—muscle cancer	0.000332	0.00122	CcSEcCtD
Bosentan—Leukopenia—Methotrexate—muscle cancer	0.000331	0.00122	CcSEcCtD
Bosentan—Chills—Doxorubicin—muscle cancer	0.00033	0.00122	CcSEcCtD
Bosentan—Cough—Methotrexate—muscle cancer	0.000323	0.00119	CcSEcCtD
Bosentan—Mental disorder—Doxorubicin—muscle cancer	0.000322	0.00119	CcSEcCtD
Bosentan—Vomiting—Etoposide—muscle cancer	0.00032	0.00118	CcSEcCtD
Bosentan—Malnutrition—Doxorubicin—muscle cancer	0.00032	0.00118	CcSEcCtD
Bosentan—Erythema—Doxorubicin—muscle cancer	0.00032	0.00118	CcSEcCtD
Bosentan—Rash—Etoposide—muscle cancer	0.000318	0.00117	CcSEcCtD
Bosentan—Dermatitis—Etoposide—muscle cancer	0.000317	0.00117	CcSEcCtD
Bosentan—Headache—Etoposide—muscle cancer	0.000316	0.00116	CcSEcCtD
Bosentan—Flatulence—Doxorubicin—muscle cancer	0.000316	0.00116	CcSEcCtD
Bosentan—Arthralgia—Methotrexate—muscle cancer	0.000315	0.00116	CcSEcCtD
Bosentan—Chest pain—Methotrexate—muscle cancer	0.000315	0.00116	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000313	0.00115	CcSEcCtD
Bosentan—Discomfort—Methotrexate—muscle cancer	0.000311	0.00115	CcSEcCtD
Bosentan—Back pain—Doxorubicin—muscle cancer	0.00031	0.00114	CcSEcCtD
Bosentan—Muscle spasms—Doxorubicin—muscle cancer	0.000308	0.00114	CcSEcCtD
Bosentan—Anaphylactic shock—Methotrexate—muscle cancer	0.000302	0.00111	CcSEcCtD
Bosentan—Vision blurred—Doxorubicin—muscle cancer	0.000302	0.00111	CcSEcCtD
Bosentan—Infection—Methotrexate—muscle cancer	0.0003	0.00111	CcSEcCtD
Bosentan—Nausea—Etoposide—muscle cancer	0.000299	0.0011	CcSEcCtD
Bosentan—Nervous system disorder—Methotrexate—muscle cancer	0.000296	0.00109	CcSEcCtD
Bosentan—Anaemia—Doxorubicin—muscle cancer	0.000296	0.00109	CcSEcCtD
Bosentan—Thrombocytopenia—Methotrexate—muscle cancer	0.000296	0.00109	CcSEcCtD
Bosentan—Skin disorder—Methotrexate—muscle cancer	0.000293	0.00108	CcSEcCtD
Bosentan—Hyperhidrosis—Methotrexate—muscle cancer	0.000292	0.00108	CcSEcCtD
Bosentan—Vertigo—Doxorubicin—muscle cancer	0.000288	0.00106	CcSEcCtD
Bosentan—Anorexia—Methotrexate—muscle cancer	0.000288	0.00106	CcSEcCtD
Bosentan—Syncope—Doxorubicin—muscle cancer	0.000287	0.00106	CcSEcCtD
Bosentan—Leukopenia—Doxorubicin—muscle cancer	0.000287	0.00106	CcSEcCtD
Bosentan—Palpitations—Doxorubicin—muscle cancer	0.000283	0.00104	CcSEcCtD
Bosentan—Hypotension—Methotrexate—muscle cancer	0.000282	0.00104	CcSEcCtD
Bosentan—Loss of consciousness—Doxorubicin—muscle cancer	0.000282	0.00104	CcSEcCtD
Bosentan—Cough—Doxorubicin—muscle cancer	0.00028	0.00103	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000275	0.00101	CcSEcCtD
Bosentan—Insomnia—Methotrexate—muscle cancer	0.000273	0.00101	CcSEcCtD
Bosentan—Arthralgia—Doxorubicin—muscle cancer	0.000273	0.00101	CcSEcCtD
Bosentan—Chest pain—Doxorubicin—muscle cancer	0.000273	0.00101	CcSEcCtD
Bosentan—Anxiety—Doxorubicin—muscle cancer	0.000272	0.001	CcSEcCtD
Bosentan—Paraesthesia—Methotrexate—muscle cancer	0.000271	0.001	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000271	0.000999	CcSEcCtD
Bosentan—Discomfort—Doxorubicin—muscle cancer	0.000269	0.000994	CcSEcCtD
Bosentan—Dyspnoea—Methotrexate—muscle cancer	0.000269	0.000993	CcSEcCtD
Bosentan—Somnolence—Methotrexate—muscle cancer	0.000268	0.00099	CcSEcCtD
Bosentan—Dry mouth—Doxorubicin—muscle cancer	0.000267	0.000984	CcSEcCtD
Bosentan—Dyspepsia—Methotrexate—muscle cancer	0.000266	0.00098	CcSEcCtD
Bosentan—Decreased appetite—Methotrexate—muscle cancer	0.000262	0.000968	CcSEcCtD
Bosentan—Anaphylactic shock—Doxorubicin—muscle cancer	0.000261	0.000964	CcSEcCtD
Bosentan—Oedema—Doxorubicin—muscle cancer	0.000261	0.000964	CcSEcCtD
Bosentan—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000261	0.000962	CcSEcCtD
Bosentan—Fatigue—Methotrexate—muscle cancer	0.00026	0.00096	CcSEcCtD
Bosentan—Infection—Doxorubicin—muscle cancer	0.00026	0.000958	CcSEcCtD
Bosentan—Pain—Methotrexate—muscle cancer	0.000258	0.000952	CcSEcCtD
Bosentan—Shock—Doxorubicin—muscle cancer	0.000257	0.000949	CcSEcCtD
Bosentan—Nervous system disorder—Doxorubicin—muscle cancer	0.000256	0.000946	CcSEcCtD
Bosentan—Thrombocytopenia—Doxorubicin—muscle cancer	0.000256	0.000944	CcSEcCtD
Bosentan—Tachycardia—Doxorubicin—muscle cancer	0.000255	0.000941	CcSEcCtD
Bosentan—Skin disorder—Doxorubicin—muscle cancer	0.000254	0.000937	CcSEcCtD
Bosentan—Hyperhidrosis—Doxorubicin—muscle cancer	0.000253	0.000932	CcSEcCtD
Bosentan—Anorexia—Doxorubicin—muscle cancer	0.000249	0.000919	CcSEcCtD
Bosentan—Gastrointestinal pain—Methotrexate—muscle cancer	0.000247	0.000911	CcSEcCtD
Bosentan—Hypotension—Doxorubicin—muscle cancer	0.000244	0.000901	CcSEcCtD
Bosentan—Urticaria—Methotrexate—muscle cancer	0.00024	0.000885	CcSEcCtD
Bosentan—Abdominal pain—Methotrexate—muscle cancer	0.000239	0.00088	CcSEcCtD
Bosentan—Body temperature increased—Methotrexate—muscle cancer	0.000239	0.00088	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000238	0.000879	CcSEcCtD
Bosentan—Insomnia—Doxorubicin—muscle cancer	0.000236	0.000872	CcSEcCtD
Bosentan—Paraesthesia—Doxorubicin—muscle cancer	0.000235	0.000866	CcSEcCtD
Bosentan—Dyspnoea—Doxorubicin—muscle cancer	0.000233	0.00086	CcSEcCtD
Bosentan—Somnolence—Doxorubicin—muscle cancer	0.000232	0.000857	CcSEcCtD
Bosentan—Dyspepsia—Doxorubicin—muscle cancer	0.00023	0.000849	CcSEcCtD
Bosentan—Decreased appetite—Doxorubicin—muscle cancer	0.000227	0.000838	CcSEcCtD
Bosentan—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000226	0.000833	CcSEcCtD
Bosentan—Fatigue—Doxorubicin—muscle cancer	0.000225	0.000832	CcSEcCtD
Bosentan—Pain—Doxorubicin—muscle cancer	0.000224	0.000825	CcSEcCtD
Bosentan—Constipation—Doxorubicin—muscle cancer	0.000224	0.000825	CcSEcCtD
Bosentan—Hypersensitivity—Methotrexate—muscle cancer	0.000222	0.000821	CcSEcCtD
Bosentan—Asthenia—Methotrexate—muscle cancer	0.000217	0.000799	CcSEcCtD
Bosentan—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000214	0.000789	CcSEcCtD
Bosentan—Pruritus—Methotrexate—muscle cancer	0.000214	0.000788	CcSEcCtD
Bosentan—Urticaria—Doxorubicin—muscle cancer	0.000208	0.000766	CcSEcCtD
Bosentan—Abdominal pain—Doxorubicin—muscle cancer	0.000207	0.000762	CcSEcCtD
Bosentan—Body temperature increased—Doxorubicin—muscle cancer	0.000207	0.000762	CcSEcCtD
Bosentan—Diarrhoea—Methotrexate—muscle cancer	0.000207	0.000762	CcSEcCtD
Bosentan—Dizziness—Methotrexate—muscle cancer	0.0002	0.000737	CcSEcCtD
Bosentan—Hypersensitivity—Doxorubicin—muscle cancer	0.000193	0.000711	CcSEcCtD
Bosentan—Vomiting—Methotrexate—muscle cancer	0.000192	0.000708	CcSEcCtD
Bosentan—Rash—Methotrexate—muscle cancer	0.00019	0.000702	CcSEcCtD
Bosentan—Dermatitis—Methotrexate—muscle cancer	0.00019	0.000702	CcSEcCtD
Bosentan—Headache—Methotrexate—muscle cancer	0.000189	0.000698	CcSEcCtD
Bosentan—Asthenia—Doxorubicin—muscle cancer	0.000188	0.000692	CcSEcCtD
Bosentan—Pruritus—Doxorubicin—muscle cancer	0.000185	0.000682	CcSEcCtD
Bosentan—Nausea—Methotrexate—muscle cancer	0.000179	0.000662	CcSEcCtD
Bosentan—Diarrhoea—Doxorubicin—muscle cancer	0.000179	0.00066	CcSEcCtD
Bosentan—Dizziness—Doxorubicin—muscle cancer	0.000173	0.000638	CcSEcCtD
Bosentan—Vomiting—Doxorubicin—muscle cancer	0.000166	0.000613	CcSEcCtD
Bosentan—Rash—Doxorubicin—muscle cancer	0.000165	0.000608	CcSEcCtD
Bosentan—Dermatitis—Doxorubicin—muscle cancer	0.000165	0.000608	CcSEcCtD
Bosentan—Headache—Doxorubicin—muscle cancer	0.000164	0.000604	CcSEcCtD
Bosentan—Nausea—Doxorubicin—muscle cancer	0.000155	0.000573	CcSEcCtD
